Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Uveitis Clinical Trials
Uveitis clinical trials are recruiting across 13 cities. Here are the cities with the most active studies:
Uveitis Trial Phases
6 research organizations are sponsoring uveitis trials.
About Uveitis
Uveitis is inflammation of the middle layer of the eye (uvea) that can cause eye pain, redness, and vision changes. It can result from infections, autoimmune conditions, or be idiopathic. Treatment includes corticosteroid eye drops, immunosuppressive medications, and biologics.
Clinical trials are advancing new treatments for uveitis. Currently, 7 studies are recruiting a combined 3,765 participants across the United States. Research is being conducted by 6 organizations including The Cleveland Clinic, Jaeb Center for Health Research, Meyer Children's Hospital IRCCS and 3 others.
2026 Uveitis Research Landscape
As of July 2026, the uveitis clinical trial landscape includes 7 actively recruiting studies across 13 cities in the United States. These studies are collectively seeking 3,765 participants, with an average enrollment target of 538 per study.
The research spans multiple phases of development: 1 study is in PHASE3, 1 study is in PHASE2. The presence of Phase 3 trials indicates that some uveitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 6 different organizations, including The Cleveland Clinic, Jaeb Center for Health Research, Meyer Children's Hospital IRCCS, Oregon Health and Science University, Texas Retina Associates, and 1 others.
Geographically, uveitis trials are most concentrated in Cleveland, Ohio (2 trials); Boston, Massachusetts (2 trials); Cincinnati, Ohio (2 trials); Akron, Ohio (1 trial); Columbus, Ohio (1 trial) and 7 other cities.
Featured Uveitis Studies
Highlighted recruiting studies for uveitis, selected by enrollment size and research scope.
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
A prospective, observational, case series investigating the feasibility of utilizing OCT scans of the anterior chamber of eyes with uveitis.
Genetics of Uveitis
In order to improve the investigators knowledge about uveitis and the underlying mechanism of disease, the investigators propose collecting blood from patients with uveitis, isolating DNA and sequencing the DNA to identify genetic mutations or associations in these patients.
A Study of Uveitis in Children <18 Years of Age
The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are: * What are the frequency of uveitis subtypes in children? * What are clinical and demographic characteristics overall and within each type of uveitis? Participants will complete one enrollment visit with their...
Frequently Asked Questions About Uveitis Clinical Trials
Are there uveitis clinical trials near me?
Yes, there are 7 uveitis clinical trials currently recruiting across 13+ cities in the United States, including Cleveland, Ohio; Boston, Massachusetts; Cincinnati, Ohio. Browse the studies above to find one at a location convenient for you.
How do I join a uveitis clinical trial?
To join a uveitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are uveitis clinical trials free?
Yes, participation in uveitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of uveitis treatments are being studied?
Current uveitis clinical trials are testing a range of approaches across PHASE3 (1 study), PHASE2 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 6 research organizations.
Is it safe to participate in uveitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov